NuCana Cash from Financing (Quarterly) Trends

NuCana PLC (NCNA)

1.23 -0.04 (-3.15%) USD | NASDAQ | Nov 22, 16:00

1.235 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	-0.0888M
March 31, 2024	1.758M
December 31, 2023	-0.0533M
September 30, 2023	0.08M
June 30, 2023	-0.0428M
March 31, 2023	-0.0498M
December 31, 2022	0.0219M
September 30, 2022	-0.0365M
June 30, 2022	-0.0855M
March 31, 2022	-0.0993M
December 31, 2021	-0.1017M
September 30, 2021	-0.103M
June 30, 2021	-0.101M
March 31, 2021	0.1709M
December 31, 2020	-0.6389M

Date	Value
September 30, 2020	77.73M
June 30, 2020	2.320M
March 31, 2020	-0.0936M
December 31, 2019	-0.0243M
September 30, 2019	-0.0242M
June 30, 2019	-0.0037M
March 31, 2019	-0.0078M
December 31, 2018	0.0391M
September 30, 2018	0.2371M
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	101.67M
September 30, 2017	-1.195M
June 30, 2017	-0.0933M
March 31, 2017	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.6389M

Minimum

Dec 2020

77.73M

Maximum

Sep 2020

4.240M

Average

-0.0498M

Median

Mar 2023

Cash from Financing (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC	25.00M
Biodexa Pharmaceuticals PLC	--
TC BioPharm (Holdings) PLC	1.183M
Mereo BioPharma Group PLC	-0.594M
Autolus Therapeutics PLC	0.185M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-1.446M
Cash from Investing (Quarterly)	-0.0053M
Free Cash Flow	-22.00M
Free Cash Flow Per Share (Quarterly)	-0.6922
Free Cash Flow Yield	-828.9%